Aethlon Medical Inc (AEMD) is not a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows weak financial performance, no positive catalysts, and bearish technical indicators. Additionally, there are no significant trading trends or influential figures supporting the stock, and no proprietary trading signals suggest a strong buy opportunity.
The stock is currently bearish with a regular market price drop of -4.92%. The MACD is slightly positive but contracting, indicating weakening momentum. The RSI is neutral at 23.425, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1.77), with resistance levels far above the current price (R1: 2.06).
NULL. No recent news, no significant trading trends, and no AI or SwingMax trading signals.
and a significant EPS drop (-75.62% YoY). The stock has a low probability of significant short-term gains (40% chance of 1.74% in the next day, 4.3% in the next week).
In Q3 2026, revenue remained at 0 with no growth. Net income improved by 15.01% YoY but remains negative at -2018245. EPS dropped significantly by -75.62% YoY, and gross margin remains at 0. Overall, the financials indicate poor performance and lack of growth.
No analyst rating or price target data available.